PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-May-2024 Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting Mainz BioMed N.V.
28-May-2024 FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication AccessWire
28-May-2024 Rehab.com Study Finds Southern States Rank Worst in Nation for Drug Abuse & Addiction AccessWire
28-May-2024 Ensysce Biosciences Regains Compliance with Nasdaq AccessWire
28-May-2024 Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab AccessWire
28-May-2024 NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model AccessWire
28-May-2024 Interventional Cardiology and Peripheral Vascular Devices Market Projected CAGR of 7.2% Wired Release
28-May-2024 Medical Aesthetic Devices Market to Reach Valuation of USD 38.91 Billion at 10.7% CAGR from 2024-2030 The Wire Times
28-May-2024 Health And Wellness Market Projects 7% CAGR Through 2033 Wired Release
28-May-2024 CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK AccessWire
28-May-2024 Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics AccessWire
28-May-2024 Exosomes Market Surges with a 34.20% CAGR, Anticipated to Hit USD 2707.8 Million by 2032 Wired Release
28-May-2024 MEK Inhibitors Market Projected to Reach Valuation of USD 6.3 Bn at 12% CAGR from 2024-2033 | Marketresearch.biz Study Wired Release
28-May-2024 Rapid Growth Predicted for Endoscopic Closure Systems Market with a 6.4% CAGR Through 2033 Wired Release
28-May-2024 Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics Secarna Pharmaceuticals GmbH & Co. KG
28-May-2024 CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK CureVac
28-May-2024 Feminine Probiotic Supplement Market Projected to Exceed USD 1,353.0 Mn by 2033 Driven by 7.6% CAGR | Research by Marketresearch.biz Wired Release
28-May-2024 Dental Implant Market Poised for 7.77% CAGR Growth Through 2032, Boosted by Cosmetic Dentistry Demand Wired Release
28-May-2024 Custom Antibody Services Market to Grow at a CAGR of 9.5% Through 2033 Wired Release
28-May-2024 Cell Therapy Monitoring Kits Market Projected to Grow at 5% CAGR Through 2033 Wired Release